<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34924406</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-3627</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>6</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Restorative neurology and neuroscience</Title><ISOAbbreviation>Restor Neurol Neurosci</ISOAbbreviation></Journal><ArticleTitle>Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment.</ArticleTitle><Pagination><StartPage>393</StartPage><EndPage>408</EndPage><MedlinePgn>393-408</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/RNN-211249</ELocationID><Abstract><AbstractText Label="BACKGROUND">An effective treatment is needed for long-COVID patients which suffer from symptoms of vision and/or cognition impairment such as impaired attention, memory, language comprehension, or fatigue.</AbstractText><AbstractText Label="OBJECTIVE">Because COVID-19infection causes reduced blood flow which may cause neuronal inactivation, we explored if neuromodulation with non-invasive brain stimulation using microcurrent (NIBS), known to enhance blood flow and neuronal synchronization, can reduce these symptoms.</AbstractText><AbstractText Label="METHODS">Two female long-COVID patients were treated for 10-13 days with alternating current stimulation of the eyes and brain. While one patient (age 40) was infected with the SARS CoV-2 virus, the other (age 72) developed symptoms following AstraZeneca vaccination. Before and after therapy, cognition was assessed subjectively by interview and visual fields quantified using perimetry. One patient was also tested with a cognitive test battery and with a retinal dynamic vascular analyser (DVA), a surrogate marker of vascular dysregulation in the brain.</AbstractText><AbstractText Label="RESULTS">In both patients NIBS markedly improved cognition and partially reversed visual field loss within 3-4 days. Cognitive tests in one patient confirmed recovery of up to 40-60% in cognitive subfunctions with perimetry results showing stable and visual field recovery even during follow-up. DVA showed that NIBS reduced vascular dysregulation by normalizing vessel dynamics (dilation/constriction), with particularly noticeable changes in the peripheral veins and arteries.</AbstractText><AbstractText Label="CONCLUSIONS">NIBS was effective in improving visual and cognitive deficits in two confirmed SARS-COV-2 patients. Because recovery of function was associated with restoration of vascular autoregulation, we propose that (i) hypometabolic, "silent" neurons are the likely biological cause of long-COVID associated visual and cognitive deficits, and (ii) reoxygenation of these "silent" neurons provides the basis for neural reactivation and neurological recovery. Controlled trials are now needed to confirm these observations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabel</LastName><ForeName>Bernhard A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wanshu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Florentina</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabel</LastName><ForeName>Kornelia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>SAVIR-Center, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonschorek</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BG Clinic Hamburg, Neurozentrum Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilc</LastName><ForeName>Mirela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Restor Neurol Neurosci</MedlineTA><NlmUniqueID>9005499</NlmUniqueID><ISSNLinking>0922-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004599" MajorTopicYN="Y">Electric Stimulation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="Y">Vision Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vision</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">corona</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">recovery</Keyword><Keyword MajorTopicYN="N">restoration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>20</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34924406</ArticleId><ArticleId IdType="pmc">PMC8764598</ArticleId><ArticleId IdType="doi">10.3233/RNN-211249</ArticleId><ArticleId IdType="pii">RNN211249</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aggarwal, K., Agarwal, A., Jaiswal, N., Dahiya, N., Ahuja, A., Mahajan, S., . . .&amp; Gupta, V. (2020). Ocular surface manifestations of coronavirus disease (COVID-19): A systematic review and meta-analysis. PLoS One, 15(11), e0241661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643964</ArticleId><ArticleId IdType="pubmed">33151999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq, I., Vrahimi, M., Waugh, S., Soomro, T., Grinton, M.E. &#x296; Browning, A.C. (2021). Acute Macular Neuroretinopathy Associated with Acute Influenza Virus Infection. International Ocular Inflammation Society, 29(2), 333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">31697568</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoli, F., Veritti, D., Danese, C., Samassa, F., Sarao, V., Rassu, N., . . .&amp; Lanzetta P. (2020). Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. Journal of Ophthalmology, ecollection 4827304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491448</ArticleId><ArticleId IdType="pubmed">32963819</ArticleId></ArticleIdList></Reference><Reference><Citation>Begemann, M.J., Brand, B.A., &#x106;ur&#x10d; i&#x107;-Blake, B., Aleman, A. &#x296; Sommer, I.E. (2020). Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. Psychological Medicine, 50(15), 2465&#x2013;2486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737055</ArticleId><ArticleId IdType="pubmed">33070785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavsar, K.V., Lin, S., Rahimy, E., Joseph, A., Freund, K.B., Sarraf, D. &#x296; Cunningham, E.T. (2016). Jr. . Acute macular neuroretinopathy: A comprehensive review of the literature. Survey Ophthalmology, 61(5), 538&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">26973287</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;hler, A.D., Str&#xf8;m, M.E., Sandvig, K.U., Moe, M.C. &#x296; J&#xf8;rstad, &#xd8;.K. (2021). Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond), 1&#x2013;2. doi: 10.1038/s41433-021-01610-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-021-01610-1</ArticleId><ArticleId IdType="pmc">PMC8217204</ArticleId><ArticleId IdType="pubmed">34158652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bola, M., Gall, C., Moewes, C., Fedorov, A., Hinrichs, H. &#x296; Sabel, B.A. (2014). Brain functional connectivity network breakdown and restoration in blindness. Neurology, 83(6), 542&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pubmed">24991030</ArticleId></ArticleIdList></Reference><Reference><Citation>Book, B.A.J., Schmidt, B. &#x296; Foerster, A.M.H. (2021). Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2. JAMA Ophthalmolology, 139(7), e212471.</Citation><ArticleIdList><ArticleId IdType="pubmed">34287612</ArticleId></ArticleIdList></Reference><Reference><Citation>Buso, G., Becchetti, C. &#x296; Berzigotti, A. (2021). Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review. Digestive and Liver Disease, 53(8), 937&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149197</ArticleId><ArticleId IdType="pubmed">34120860</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande, M., Fitzek, A., P&#xfc;schel, K., Aleshcheva, G., Schultheiss, H.P., Berneking, L., Spitzer, M.S. &#x296; Schultheiss, M. (2020). Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients. Oculular Immunology Inflammation, 28(5), 721&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, C.S., Li, C.T., Brunoni, A.R., Yang, F.C., Tseng, P.T., Tu, Y.K., . . . &amp; Liang, C.S. (2021). Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer&#x2019;s disease and mild cognitive impairment: a component network meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry, 92(2), 195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841477</ArticleId><ArticleId IdType="pubmed">33115936</ArticleId></ArticleIdList></Reference><Reference><Citation>Dr&#xfc;ke, D., Pleyer, U., Hoerauf, H., Feltgen, N. &#x296; Bemme, S. (2021). Acute macular neuroretinopathy (AMN) following COVID-19 vaccination. American Journal of Ophthalmology Case Report, 24, 101207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457905</ArticleId><ArticleId IdType="pubmed">34580648</ArticleId></ArticleIdList></Reference><Reference><Citation>Erb, W. (1882). Handbuch der Elektrotherapie. Verlag V.C.W. Vogel; Leipzig.</Citation></Reference><Reference><Citation>Fedorov, A., Jobke, S., Bersnev, V., Chibisova, A., Chibisova, Y., Gall, C. &#x296; Sabel, B. A. (2011). Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observational study. Brain Stimulation, 4(4), 189&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">21981854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall, C., Schmidt, S., Schittkowski, M.P., Antal, A., Ambrus, G.G., Paulus, W., Dannhauer, M., . . .&amp; Sabel, B.A. (2016). Alternating current stimulation for vision restoration after optic nerve damage: a randomized clinical trial. PLoS One, 11, e0156134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927182</ArticleId><ArticleId IdType="pubmed">27355577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall, C., Sgorzaly, S., Schmidt, S., Brandt, S., Fedorov, A. &#x296; Sabel, B. A. (2011). Noninvasive transorbital alternating current stimulation improves subjective visual functioning and vision related quality of life in optic neuropathy. Brain Stimulation, 4(4), 175&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">21981853</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall, C., Schmidt, S., Schittkowski, M. P., Antal, A., Ambrus, G. G., Paulus, W., ...&amp; Sabel, B.A. (2016). Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial. PLoS One, 11(6), e0156134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927182</ArticleId><ArticleId IdType="pubmed">27355577</ArticleId></ArticleIdList></Reference><Reference><Citation>Garhofer, G., Bek, T., Boehm, A.G., Gherghel, D., Grunwald, J., Jeppesen, P., . . .&amp; Schmetterer, L. (2010). Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmologica, 88(7), 717&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">19681764</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubnitschaja, O. 2019. (Ed.) &#x201c;Flammer Syndrome: From Phenotype to Associated Pathologies, Prediction, Prevention and Personalisation&#x201d;, Springer, Berlin, Germany.</Citation></Reference><Reference><Citation>Guedj, E., Campion, J.Y., Dudouet, P., Kaphan, E., Bregeon, F., Tissot-Dupont, H., . . .&amp; Eldin C. (2021). 18F-FDG brain PET hypometabolism in patients with long COVID. European Journal of Nuclear Medicine and Molecular Imaging, 48(9), 2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Guemes-Villahoz, N., Burgos-Blasco, B., Vidal-Villegas, B., Donate-L&#xf3;pez, J., de la Muela, M.H., L&#xf3;pez-Guajardo, L., Mart&#xed;n-S&#xe1;nchez, F.J. &#x296; Garc&#xed;a-Feijo&#xf3;, J. (2021). Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography. Graefes Archive for Clinical and Experimental Ophthalmology, 259(8), 2243&#x2013;2249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102150</ArticleId><ArticleId IdType="pubmed">33961108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugleta, K., Kochkorov, A., Waldmann, N., Polunina, A., Katamay, R., Flammer, J. &#x296; Orgual, S. (2012). Dynamics of retinal vessel response to flicker light in glaucoma patients and ocular hypertensives. Graefes Archive for Clinical and Experimental Ophthalmology, 250(4), 589&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">22008947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire, A., Trender, W., Chamberlain, S.R., Jolly, A.E., Grant, J.E., Patrick, F., . . .&amp; Mehta, M.A. (2021). Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine, 39, 101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp, J.A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., . . . &amp; Meyer, P.T. (2021). Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain, 144(4), 1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob, B. &#x296; Wiwanitkit, V. (2021). Blood viscosity of COVID-19 patient: a preliminary report. American Journal of Blood Research, 11(1), 93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010604</ArticleId><ArticleId IdType="pubmed">33796395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, N., Lee, R.D., Lee J.H. &#x296; Hwang M.H. (2020). Functional balance and postural control improvements in patients with stroke after noninvasive brain stimulation: a meta-analysis. Archives of Physical Medicine and Rehabilitation, 101(1), 141&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">31568760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisely, S., Li, A., Warren, N. &#x296; Siskind, D. (2018). A systematic review and meta-analysis of deep brain stimulation for depression. Depression and Anxiety, 35(5), 468&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">29697875</ArticleId></ArticleIdList></Reference><Reference><Citation>Konieczka, K. &#x296; Flammer, J. (2016). Phenomenology and Clinical Relevance of the Flammer Syndrome. Klinische Monatsbl&#xe4;tter f&#xfc;r Augenheilkunde, 233, 1331&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">27984835</ArticleId></ArticleIdList></Reference><Reference><Citation>Konieczka, K., Ritch, R., Traverso, C.E., Kim, D.M., Kook, M.S., Gallino, A., Golubnitschaja, O., Erb, C., Reitsamer, H.A., Kida, T., Kurysheva, N. &#x296; Yao, K. (2014). Flammer syndrome. EPMA Journal, 5, eCollection.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4113774</ArticleId><ArticleId IdType="pubmed">25075228</ArticleId></ArticleIdList></Reference><Reference><Citation>Landecho, M.F., Yuste, J.R., G&#xe1;ndara, E., Sunsundegui, P., Quiroga, J., Alcaide, A.B. &#x296; Garc&#xed;a-Layana, A. (2021). COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? Journal of Internal Medicine, 289(1), 116&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne, S.J., Winters, M.F., Pizzagalli, D.A. &#x296; Olmstead, M.C. (2021). Post-acute sequelae of COVID-19: Evidence of mood &amp; cognitive impairment. Brain Behavior &amp; Immunity Health, 17, 100347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lani-Louzada, R., Ramos, C.D.V.F., Cordeiro, R.M. &#x296; Sadun, A.A. (2020). Retinal changes in COVID-19 hospitalized cases. PLoS One, 15(12), e0243346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714146</ArticleId><ArticleId IdType="pubmed">33270751</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby, P. &#x296; L&#xfc;scher, T. (2020). COVID-19 is, in the end, an endothelial disease. European Heart Journal, 41(32), 3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y.H., Wang, Y.R., Wang, Q.H., Chen, Y., Chen, X., Li, Y., . . . &amp; Wang, Y.J. (2021). Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Molecular Neurodegeneration, 16(1), 48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Longden, T.A., Dabertrand, F., Koide, M., Gonzales, A.L., Tykocki, N.R., Brayden, J.E., Hill-Eubanks, D. &#x296; Nelson, M.T. (2017). Capillary+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow. Nature Neuroscience, 20(5), 717&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404963</ArticleId><ArticleId IdType="pubmed">28319610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac&#xe9;, T. &#x296; Pipelart, V. (2021). Acute macular neuroretinopathy and SARS-CoV-2 infection: Case report.ais D&#x2019;Ophtalmologie. Journal Fran&#xe7;ais D&#x2019;Ophtalmologie, 44(9), e519&#x2013;e521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426190</ArticleId><ArticleId IdType="pubmed">34625310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mambretti, M., Huemer, J., Torregrossa, G., Ullrich, M., Findl, O. &#x296; Casalino, G. (2021), Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination. Oculular Immunology and Inflammation, 29(4), 730&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">34187278</ArticleId></ArticleIdList></Reference><Reference><Citation>Masjedi, M., Pourazizi, M. &#x296; Hosseini, N.S. (2021). Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019: A case report. Clinical Case Reports, 9, e04976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521194</ArticleId><ArticleId IdType="pubmed">34703607</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak, K.W., Johnsen, S., Sattler, S.M., Nielsen, S., Kunalan, K., Rungby, J., Lapperre, T. &#x296; Porsberg, C.M. (2021). Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. European Neuropsychopharmacology, 46, 39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitsche, M.A. &#x296; Paulus, W. (2000). Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. The Journal of Physiology, 527, 633&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2270099</ArticleId><ArticleId IdType="pubmed">10990547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek, M., Rayner, C., Freyer, A., Taylor, S., J&#xe4;rte, L., MacDermott, N. &#x296; Delaney B.C., Delphi panellists. (2021). Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. British Journal of General Practice, 71(712), e815&#x2013;e825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard, L. (2021). SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiological Reports, 9(3), e14726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A.D. &#x296; VanElzakker M.D. (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology, 12, 698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Querques, G., Borrelli, E., Sacconi, R., De Vitis, L., Leocani, L., Santangelo, R., . . . &#x269; Bandello, F. (2019). Functional and morphological changes of the retinal vessels in Alzheimer&#x2019;s disease and mild cognitive impairment. Scientific Reports, 9(1), 63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329813</ArticleId><ArticleId IdType="pubmed">30635610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Fedorov, A.B., Naue, N., Borrmann, A., Herrmann, C. &#x296; Gall, C. (2011). Non- invasive alternating current stimulation improves vision in optic neuropathy. Neurology and Neuroscience, 29(6), 493&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">22124039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Flammer, J. &#x296; Merabet, L.B. (2018). Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness &#x2013;a review. Restorative Neurology and Neuroscience, 36, 767&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6294586</ArticleId><ArticleId IdType="pubmed">30412515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Hamid, A.I.A., Borrmann, C., Speck, O. &#x296; Antal, A., (2020. a). Transorbital alternating current stimulation modifies BOLD activity in healthy subjects and in a stroke patient with hemianopia: A 7 Tesla fMRI feasibility study. International Journal of Psychophysiology, 154, 80&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">30978369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Kresinsky, A., C&#xe1;rdenas-Morales, L., Haueisen, J., Hunold, A., Dannhauer, M. &#x296; Antal, A. (2021). Evaluating current density modeling of non-invasive eye and brain electrical stimulation using phosphene thresholds, IEEE TNSRE, 29, 2133-2141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8594910</ArticleId><ArticleId IdType="pubmed">34648453</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Thut, G., Haueisen, J., Henrich-Noack, P., Herrmann, C.S., Hunold, A. &#x296; Antal, A. (2020. b). Vision modulation, plasticity and restoration using non-invasive brain stimulation &#x2013;An IFCN-sponsored review. Clinical Neurophysiology, 131, 887&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">32078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel, B.A., Wang, J., C&#xe1;rdenas-Morales, L., Faiq, M., Heim, C. &#x296; Golubnitschaja, O. (2019). Flammer Syndrome: Psychological Causes and Consequences of Visual Impairment. In: O. Golubnitschaja (Ed.) &#x201c;Flammer Syndrome: From Phenotype to Associated Pathologies, Prediction, Prevention and Personalisation&#x201d;, Springer, Berlin, Germany, pp. 29&#x2013;77.</Citation></Reference><Reference><Citation>Sabel, B.A., Wang, J., F&#xe4;hse, S., Cardenas-Morales, L. &#x296; Antal, A. (2020. c). Personality and stress influence vision restoration and recovery in glaucoma and optic neuropathy following alternating current stimulation: implications for personalized neuromodulation and rehabilitation. EPMA Journal, 11, 177&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272530</ArticleId><ArticleId IdType="pubmed">32547650</ArticleId></ArticleIdList></Reference><Reference><Citation>Santovito, L.S. &#x296; Pinna, G. (2021). Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine nd dose: a case report. Inflammation Research, 70(9), 931&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8176659</ArticleId><ArticleId IdType="pubmed">34086060</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifert, B.U. &#x296; Vilser, W. (2002). Retinal Vessel Analyzer (RVA) &#x2013;design and function. Biomedizinische Technik (Berl), 47(Suppl 1) Pt 2), 678&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">12465272</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegert, A., Diedrich, L. &#x296; Antal, A. (2021). New Methods, old Brains-a systematic review on the effects of tDCS on the cognition of elderly people. Frontiers in Human Neuroscience, 27(15), 730134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8578968</ArticleId><ArticleId IdType="pubmed">34776903</ArticleId></ArticleIdList></Reference><Reference><Citation>Teselink, J., Bawa, K.K., Koo, G.K., Sankhe, K., Liu, C.S., Rapoport, M., . . . &amp; Lanct&#xf4;t, K.L. (2021). Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer&#x2019;s disease and mild cognitive impairment: A meta-analysis and systematic review. Ageing Research Reviews, 72, 101499.</Citation><ArticleIdList><ArticleId IdType="pubmed">34700007</ArticleId></ArticleIdList></Reference><Reference><Citation>Westwood, S.J., Radua, J. &#x296; Rubia, K. (2021). Noninvasive brain stimulation in children and adults with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Psychiatry &amp; Neuroscience, 46(1), E14&#x2013;E33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955851</ArticleId><ArticleId IdType="pubmed">33009906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Z. &#x296; Sabel, B.A. (2021). Spacetime in the brain: rapid brain network reorganization in visual processing and recovery. Scientific Reports, 11, 17940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429559</ArticleId><ArticleId IdType="pubmed">34504129</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela, D.A., Groth, S., Taubenslag, K.J. &#x296; Gangaputra, S. (2021). Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. American Journal of Ophthalmology Case Reports, 24, 101200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409052</ArticleId><ArticleId IdType="pubmed">34485760</ArticleId></ArticleIdList></Reference><Reference><Citation>Virchow, R. Weitere Untersuchungen &#xfc;ber die Verstopfung der Lungenarterien und ihre Folge. Traube&#x2019;s Beitr&#xe4;ge experimentelle Patholologie und Physiologie, 1846, 2. Jg., S. 21&#x2013;31.</Citation></Reference><Reference><Citation>Virgo, J. &#x296; Mohamed, M. (2020). Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond), 34(12), 2352&#x2013;2353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333786</ArticleId><ArticleId IdType="pubmed">32620843</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO (download 21 Nov 2021): https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>